Research & Development



  “滾!”   因為他們一面旗幟。伊人在线大香蕉   一面大紅的用金絲織成的嫁衣。大香蕉   總之,不論什麼好東西,想要大規模推廣售賣之前,先要過雲氏的婆子們這一關。大香蕉网站   說著話,何愁有又無奈的朝窗外的那顆春樹看了一眼,偷偷看了雲音一眼,絕望的哀嘆一聲。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo